enlightenVue
Private Company
Total funding raised: $15.2M
Overview
enlightenVue is a private, commercial-stage medical device company pioneering a novel single-use micro-endoscope platform. Its FDA 510(k)-cleared SurgiVue device combines a 2mm diameter with two working channels, aiming to reduce infection risk, lower procedural costs, and expand minimally invasive access to small body cavities. The company is leveraging the high-growth single-use endoscopy market segment, with a leadership team possessing strong commercial and clinical expertise to drive adoption in targeted surgical specialties.
Technology Platform
SurgiVue™ single-use micro-endoscope platform featuring a 2mm outer diameter (industry's smallest), two working channels, flush ports, superior optics, and a patented expandable tip for combined diagnostic and therapeutic interventions.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
EnlightenVue competes in the single-use endoscopy market against large players like Boston Scientific (SpyGlass™), Ambu, and Olympus, as well as other startups. Its primary differentiation is the combination of the industry's smallest 2mm diameter with dual working channels for therapy, targeting a niche of ultra-minimally invasive procedures not well addressed by current offerings.